Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties. 2017

Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev trg 20, P. O. Box 177, HR-10000 Zagreb, Croatia.

Within this manuscript design, synthesis of novel 2-imidazolinyl substituted benzo[b]thieno-2-carboxamides bearing either benzimidazole or benzothiazole subunit and biological activity are presented and described. The antiproliferative activities were assessed in vitro on a panel of human cancer cell lines. Tested compounds showed moderate activity while cytotoxicity on normal fibroblasts was lower in comparison with 5-fluorouracile. The variations of 2-imidazolinyl substituent at heteroaromatic subunits in different positions led to different cytotoxic properties. The strongest selective activity against HeLa cells was observed for the benzothiazole derivative 4d with 2-imidazolinyl group at the benzo[b]thiophene subunit with a corresponding IC50 = 1.16 μM. Additionally, several biological experiments were performed to explain the mode of biological action. Fluorescence microscopy evidenced nuclear subcellular localization of compounds 3a, 4a and 4c. Additionally, detailed DNA binding studies confirmed a strong DNA groove binding for derivatives 4a and 4c while DNase I footprinting experiments evidenced sequence-selective binding of compound 4c in the A-T rich side. Furthermore, topoisomerase suppressive effect was for compounds 4a-4c.

UI MeSH Term Description Entries
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000578 Amidines Derivatives of oxoacids RnE(
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene

Related Publications

Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
August 2018, Molecular diversity,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
September 2023, ChemMedChem,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
October 2019, Antioxidants (Basel, Switzerland),
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
April 2006, Bioorganic & medicinal chemistry,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
January 2015, European journal of medicinal chemistry,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
August 2006, European journal of medicinal chemistry,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
June 2006, Bioorganic & medicinal chemistry letters,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
July 2023, Future medicinal chemistry,
Maja Cindrić, and Samy Jambon, and Anja Harej, and Sabine Depauw, and Marie-Hélène David-Cordonnier, and Sandra Kraljević Pavelić, and Grace Karminski-Zamola, and Marijana Hranjec
April 2015, Marine drugs,
Copied contents to your clipboard!